関連する実験動画
Updated: Jul 18, 2025

08:29
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
10.0K
染色体不安定による非細胞自律がんの進行
Jun Li1,2, Melissa J Hubisz3,4,5,6, Ethan M Earlie3,4,5
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature
|August 23, 2023
まとめ
染色体不安定性 (CIN) は,cGAS- STING経路を活性化し,転移性腫瘍環境を作り出すことにより,癌の転移を促します. この経路への介入は,特に免疫能力のある環境では,転移を抑制します.
科学分野:
- 腫瘍学
- 免疫学
- 遺伝学
背景:
- 染色体不安定性 (CIN) は,癌の転移の要因として知られている.
- CINによる転移における免疫系の役割は完全に理解されていません.
研究 の 目的:
- CINによるcGAS-STING経路の慢性的な活性化が腫瘍の微小環境と転移にどのように影響するかを調査する.
- cGAS-STING経路を標的とした治療戦略を研究する.
主な方法:
- 単細胞のトランスクリプトミックのデータから細胞間の相互作用を分析するための新しいツールであるコンタクトトレーシングを使用した.
- cGAS- STING経路の活性化,インターフェロン反応,および内 плазма網膜 (ER) ストレスを含む,癌細胞におけるCIN誘発信号の研究.
- CINの逆転,STINGの減少,およびERのストレス抑制が免疫能力のあるモデルおよび免疫能力の低下したモデルにおける転移への影響を評価した.
- メラノーマ,乳がん,大腸がんの臨床前モデルで評価されたSTING阻害剤.
- CIN,cGAS活性化,ERストレス,転移との関連性について,ヒトのトリプルネガティブ乳がん (TNBC) を分析した.
主要な成果:
- CIN誘発によるcGAS- STINGの活性化により,がん細胞のシグナル再配線が起こり,転移を促す腫瘍の微環境が形成されます.
- この再配線は,STINGの下流のタイプIインターフェロンタキフィラキスを含み,ERのストレスを増加させます.
- CINを逆転させ,STINGを抑制したり,ERストレスを阻害したりすることで,CINに依存する転移前効果を無効化し,免疫能力のある環境で転移を抑制します.
- STING阻害剤は,腫瘍細胞内にあるSTINGに依存する様々な癌のCIN誘発性転移を効果的に抑制する.
- 人間のTNBCにおけるCINとcGASの活性化は,ERストレス,免疫抑制,転移と相関する.
結論:
- cGAS- STING経路と,その後のERストレスは,CIN主導の転移の重要なメディエーターです.
- 腫瘍細胞に内在するSTINGを標的とした治療は CINが誘発する癌に対する有望な治療戦略です
- CIN誘発の炎症と関連するERストレスは,特にTNBCでは転移と免疫抑制の重要な要因です.
関連する概念動画
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

